Azacitidine and Entinostat in Treating Patients With Advanced Breast Cancer
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Male Breast Carcinoma|Recurrent Breast Carcinoma|Stage IIIC Breast Cancer AJCC v7|Stage IV Breast Cancer AJCC v6 and v7|Triple-Negative Breast Carcinoma
Interventions: DRUG: Azacitidine|DRUG: Entinostat|OTHER: Laboratory Biomarker Analysis|OTHER: Pharmacological Study
Sponsor: National Cancer Institute (NCI)